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Syndrome
One of the most common subtypes of myelodysplastic
syndrome (MDS) is associated with a recurrent deletion
on chromosome 5q. People with the 5q syndrome have
a chronic, severe anemia that is often refractory to stan-
dard treatment, and they have dysplastic megakaryocytes
in their bonemarrow. The critical region for 5q syndrome
is a 1.5 Mb region that contains at least 24 genes, making it
difﬁcult to tease apart the mechanism that leads to MDS.
Two recent papers in Nature Medicine take very different
approaches to this problem, and each identiﬁes what
appears to be a key pathway involved in 5q syndrome.
Starczynowski et al. looked for microRNAs in the 5q crit-
ical region and found two, miR-145 andmiR-146a, that are
expressed at lower-than-normal levels in bone marrow
samples from people with MDS. Reduced expression of
these miRNAs, in turn, leads to increased activation of
innate immune signaling in hemoatopoietic stem and pro-
genitor cells, including elevated IL-6 expression. This is not
the same pathway implicated in 5q syndrome by Barlow
et al., who used chromosome engineering methods to
delete mouse chromosomal regions that are syntenic to
the human 5q critical region. A deletion on mouse
chromsome 18, which includes Rps14, leads to macrocytic
anemia and abnormal megakaryocyte development,
features that resemble MDS. Many of these hematopoietic
deﬁcits are rescued when these mice are crossed to a
Trp53/ strain, implicating p53 signaling in the develop-
ment of 5q syndrome. Together, these papers suggest
that a single gene in the 5q critical region is not the
key to the development of MDS. Rather, they implicate
two separate signaling pathways as being important for
development of this syndrome.
Starczynowski et al. (2010). Identiﬁcation of miR-145 and
miR-146a as mediators of the 5q- syndrome phenotype.
Nat. Med. 16, 49–58.
Barlow et al. (2010). A p53-dependent mechanism underlies
macrocytic anemia in a mouse model of human 5q- syndrome.
Nat. Med. 16, 59–66.
Boy, Are You Different!
If you look at our autosomes, it is remarkable how similar
we are in DNA sequence to chimpanzees. The unique
nature of the Y chromosome suggests it has evolved
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The Americagenome, and some have predicted that the Y chromosome
might actually be more similar between humans and
chimps than is the rest of the genome. In fact, the opposite
is true. The ﬁrst high-resolution sequence of the chim-
panzee Y chromosome has been completed by Hughes
et al., who ﬁnd dramatic differences in the chimpanzee Y
chromosome compared to the human Y. Almost one-third
of the male-speciﬁc sequence on the chimpanzee Y chro-
mosome is not found on the human Y, and vice versa,
whereas less than 2% of sequence lacks a human counter-
part in other parts of the genome. Many of these unique
sequences on the two Y chromosomes are found in the
palindromic regions, which have the potential for rapid
structural change. The palindromic regions on the chim-
panzee Y chromosome are even more complicated than
those on the human Y; there are many more palindromes
on the chimp Y, and most of them exist in multiple copies.
These features provide more potential substrates for inter-
and intra-chromosome nonhomologous allelic recombi-
nation. Although structurally more complicated, however,
the chimp Y encodes far fewer genes and gene families
than the human Y. If this is what we see in our closest
relative, imagine the differences that we might see as
more Y chromosomes are sequenced.
Hughes et al. (2010). Chimpanzee and human Y chromo-
somes are remarkably divergent in structure and gene content.
Nature. Published online January 13, 2010. 10.1038/
nature08700.
Identifying the Achilles Heel of the Tasmanian Devil
The Tasmanian devil population is endangered because of
a transmissible cancer, devil facial tumor disease (DFTD),
that has decimated the population. You might immedi-
ately think DFTD must be caused by a virus, but this
rapidly fatal cancer is actually passed between animals
as a clonal allograft when they bite each other. The lack
of diversity in the species contributes to the problem by
limiting the immune recognition of this allograft as a
foreign invader. Beyond this, very little is known about
DFTD, and there is a lack of diagnostic tests and therapies
for the disease. Murchison et al. ﬁgured one of the ﬁrst
things to knowwould be the identity of the tissue in which
the original cancer arose, and they determined this
through expression proﬁling of tumors. Gene expression
in DFTD tumors most closely resembles the expression
proﬁles of peripheral nerves, implicating this tissue as theta, GA 30322, USA
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origin of the tumor. Although it’s the tip of the iceberg, this
knowledge lets us begin to think about how this cancer
arose and why it can spread so effectively. The ﬁndings
also have a direct and immediate diagnostic application.
Murchison et al. tested expression of several peripheral
nerve proteins in DFTD tumors in the hopes of identifying
a histological marker for DFTD. They found that the
normally Schwann-cell-speciﬁc protein periaxin was ex-
pressed in all of the DFTD tumors and mestastases tested,
making it the ﬁrst diagnostic marker for the disease. This
test could help with the management of the infection in
Tasmania because it allows for the identiﬁcation of in-
fected devils so that they can be isolated to potentially
limit the spread of the infection.
Murchison et al. (2010). The Tasmanian devil transcriptome
reveals schwann cell origins of a clonally transmissible cancer.
Science 327, 84–87.
Axon Misguidance Due to Defective Microtubules
Functional microtubules are a requirement for proper
development of the nervous system. Mutations in partic-
ular tubulin isotypes have already been identiﬁed as causes
of lissencephaly and polymicrogyria, defects that appar-
ently result from aberrant neuronal migration. Tischﬁeld
et al. now report that one type of tubulin, the neuron-
speciﬁc b-tubulin isotype III that is encoded by TUBB3, is
needed for proper axon guidance rather than neuronal
migration. TUBB3 mutations cause a range of nervous
system disorders that all include ocular motility problems
due to hypoplasia of the oculomotor nerve. In addition
to isolated defects of the eye, other features of these
syndromes can include dysgenesis of the corpus collosum
and progressive sensorimotor polyneuropathy. A total of
29 unrelated families had missense TUBB3 mutations,
many of them recurrent. To some extent, the precise muta-
tion present in a family can suggest the clinical outcome,
and the authors used a variety of experimental systems
to explore the molecular defects associated with each
mutation. Differences in the effects of each mutation on
microtubule dynamics, heterodimer formation, and the
interactions of the microtubules with kinesin proteins
might at least partially explain the genotype-phenotype
correlations.
Tischﬁeld et al. (2010). Human TUBB3 mutations perturb
microtubule dynamics, kinesin interactions, and axon guid-
ance. Cell 74, 74–87.106 The American Journal of Human Genetics 86, 105–107, FebruaryConserved Role in Meiotic Recombination
for the Rapidly Evolving Gene PRDM9
Meiotic recombination in mammals tends to occur prefer-
entially at certain sites, termed hotspots. At least for some
hotspots, the DNA sequence in the region is involved in
selection of the site of recombination, including a 13 bp
motif that is overrepresented at human hotspots. How
did these hotspots evolve, given that the process of recom-
bination means that the noninitiating allele is used as a
template for gene conversion to correct the initiating,
recombination-prone allele, giving rise to the ‘‘recombina-
tion hotspot paradox’’? Three recent papers suggest that
the same protein, PRDM9, controls the location of recom-
bination hotspots in humans and in mice, and they
suggest that this gene displays a striking evolutionary
pattern that may counteract the recombination paradox.
PRDM9 is a zinc-ﬁnger protein that recognizes the human
hotspot motif. Variation in this gene explains a signiﬁcant
fraction of interindividual variation in hotspot usage in
humans. Similarly, variation in murine Prdm9 controls
hotspot usage, suggesting conservation of this system in
mammals. Yet the work by Myers et al. demonstrates that
chimpanzee PRDM9 does not recognize the same hotspot
motif used in humans, which at least partially explains
the fact that humans and chimpanzees do not share
recombination hotspot motifs. Sequence comparisons
between mammalian species indicate that PRDM9 is a
rapidly evolving gene, and this could tie into the lack of
conservation in recombination hotspots between species.
Changing even a single amino acid in one of PRDM9’s
zinc ﬁngers appears to be able to confer newDNA sequence
speciﬁcity for protein binding, which could explain the
creation of new hotspots. Thus, although the recombina-
tion paradox would appear to be removing hotspots from
genomes, positive selection on the binding speciﬁcity for
PRDM might have counteracted this loss by driving the
protein to recognize new DNA motifs as hotspots.
Myers et al. (2009). Drive against motifs in primates impli-
cates the PRDM9 gene in meiotic recombination. Science. Pub-
lished online December 31, 2009. 10.1126/science.1182363.
Parvanov et al. (2009). Prdm9 controls activation of
mammalian recombination hotspots. Science. Published online
December 31, 2009. 10.1126/science.1181495.
Baudat et al. (2009). PRDM9 is a major determinant of
meiotic recombination hotspots in humans and mice. Published
online December 31, 2009. 10.1126/science.1183439.This month in Our Sister JournalsDetection of Mosaicism by Array CGH
With traditional cytogenetic analysis, the chromosomes
from individual cells are analyzed, so it is straightforward
to ﬁnd cell-to-cell variation in chromosome structure,which can reﬂect underlying mosaicism. The sensitivity
for detection of mosaicism with this approach is deter-
mined by the number of cells analyzed. With array-based
comparative genomic hybridization (aCGH), in contrast,12, 2010
DNA from multiple cells is simultaneously bound to the
array for analysis. Use of aCGH increases the resolution
for detection of cytogenetic abnormalities, but the sensi-
tivity of oligonucleotide-based aCGH for detection of
mosaicism is not clear. Scott et al. assessed this sensitivity
by spiking arrays with known ratios of normal to abnormal
samples. They report that, with the right analysis, they can
detect mosaicism for aneuploidy when it is present at a
level as low as 10% and for segmental aneuploidies when
these composed 20%–30% of the sample. A word of
caution, though: these levels of detection were only
achieved through use of dye-swap replicates and in the
absence of data ﬁltering, a procedure that would increaseThe Americafalse-positive results in routine use. Traditional cytogenetic
analysis of cultured cells was also compared to analysis of
uncultured cells by aCGH. This yielded an unexpected
ﬁnding —discordant results between the aCGH and the
karyotype from cultured cells, particularly for double aneu-
ploid samples. The authors believe that aCGH was able to
detect previously unidentiﬁed placental mosaicism, but
the discrepancy between the results suggests that caution
should be used in the interpretation aCGH performed on
uncultured cells.
Scott et al. (2010). Detection of low-level mosaicism and
placentalmosaicismbyoligonucleotidearray comparativegenomic
hybridization. Gen. Med. 10.1097/GIM.0b013e3181cc75d0.n Journal of Human Genetics 86, 105–107, February 12, 2010 107
